Jiang C - Search Results

1

Robust and interpretable deep learning system for prognostic stratification of extranodal natural killer/T-cell lymphoma.

Jiang C, Jiang Z, Zhang X, Qu L, Fu K, Teng Y, Lai R, Guo R, Ding C, Li K, Tian R. Jiang C, et al. Among authors: jiang z. Eur J Nucl Med Mol Imaging. 2024 Dec 23. doi: 10.1007/s00259-024-07024-x. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39714634

2

Value of ¹⁸F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen.

Jiang C, Teng Y, Chen J, Wang Z, Zhou Z, Ding C, Xu J. Jiang C, et al. Ann Nucl Med. 2020 Dec;34(12):911-919. doi: 10.1007/s12149-020-01536-w. Epub 2020 Oct 15. Ann Nucl Med. 2020. PMID: 33057996

3

Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma.

Jiang C, Li A, Teng Y, Huang X, Ding C, Chen J, Xu J, Zhou Z. Jiang C, et al. Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2902-2916. doi: 10.1007/s00259-022-05717-9. Epub 2022 Feb 11. Eur J Nucl Med Mol Imaging. 2022. PMID: 35146578

4

Robust deep learning-based PET prognostic imaging biomarker for DLBCL patients: a multicenter study.

Jiang C, Qian C, Jiang Z, Teng Y, Lai R, Sun Y, Ni X, Ding C, Xu Y, Tian R. Jiang C, et al. Among authors: jiang z. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3949-3960. doi: 10.1007/s00259-023-06405-y. Epub 2023 Aug 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 37606859

5

Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.

Jiang C, Zhang X, Jiang M, Zou L, Su M, Kosik RO, Tian R. Jiang C, et al. Among authors: jiang m. Ann Nucl Med. 2015 Jun;29(5):442-51. doi: 10.1007/s12149-015-0964-8. Epub 2015 Mar 24. Ann Nucl Med. 2015. PMID: 25801633

6

The Deauville 5-Point Scale Improves the Prognostic Value of Interim FDG PET/CT in Extranodal Natural Killer/T-Cell Lymphoma.

Jiang C, Su M, Kosik RO, Zou L, Jiang M, Tian R. Jiang C, et al. Among authors: jiang m. Clin Nucl Med. 2015 Oct;40(10):767-73. doi: 10.1097/RLU.0000000000000892. Clin Nucl Med. 2015. PMID: 26164182

7

A pulmonary chondromatous hamartoma resembling multiple metastases in the (18)F-FDG PET/CT scan.

Li L, Jiang C, Tian R. Li L, et al. Among authors: jiang c. Hell J Nucl Med. 2016 May-Aug;19(2):176-8. doi: 10.1967/s002449910376. Epub 2016 Jun 22. Hell J Nucl Med. 2016. PMID: 27331216

8

Predictive approaches for post-therapy PET/CT in patients with extranodal natural killer/T-cell lymphoma: a retrospective study.

Jiang C, Liu J, Li L, Kosik RO, Su M, Zou L, Tian R. Jiang C, et al. Nucl Med Commun. 2017 Nov;38(11):937-947. doi: 10.1097/MNM.0000000000000731. Nucl Med Commun. 2017. PMID: 28858180

9

Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis.

Wang H, Shen G, Jiang C, Li L, Cui F, Tian R. Wang H, et al. Among authors: jiang c. PLoS One. 2018 Mar 20;13(3):e0194435. doi: 10.1371/journal.pone.0194435. eCollection 2018. PLoS One. 2018. PMID: 29558489 Free PMC article.

10

Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL).

Jiang C, Teng Y, Chen J, Wang Z, Zhou Z, Ding C, Xu J. Jiang C, et al. EJNMMI Res. 2020 Sep 23;10(1):110. doi: 10.1186/s13550-020-00698-y. EJNMMI Res. 2020. PMID: 32965554 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,660 results

Search Page

Filters